Rachel E Williams

Summary

Affiliation: GlaxoSmithKline Research and Development
Country: USA

Publications

  1. ncbi request reprint Healthcare seeking and treatment for menopausal symptoms in the United States
    Rachel E Williams
    Worldwide Epidemiology, GlaxoSmithKline, PO Box 13398, Mailstop 17 2116, Five Moore Drive, Research Triangle Park, NC 27709 3398, USA
    Maturitas 58:348-58. 2007
  2. pmc Lean mass, muscle strength, and physical function in a diverse population of men: a population-based cross-sectional study
    Andre B Araujo
    New England Research Institutes, Inc, Watertown, MA, USA
    BMC Public Health 10:508. 2010
  3. doi request reprint Menopause-specific questionnaire assessment in US population-based study shows negative impact on health-related quality of life
    Rachel E Williams
    Worldwide Epidemiology, GlaxoSmithKline, PO Box 13398, Mailstop 17 2116, Five Moore Drive, Research Triangle Park, NC 27709 3398, USA
    Maturitas 62:153-9. 2009
  4. ncbi request reprint Stability of irritable bowel syndrome using a Rome II-based classification
    R E Williams
    Worldwide Epidemiology, Glaxo SmithKline, Research Triangle Park, NC 27709, USA
    Aliment Pharmacol Ther 23:197-205. 2006
  5. ncbi request reprint Determinants of healthcare-seeking behaviour among subjects with irritable bowel syndrome
    R E Williams
    Worldwide Epidemiology, GlaxoSmithKline, Research Triangle Park, NC 27709 3395, USA
    Aliment Pharmacol Ther 23:1667-75. 2006
  6. pmc Prevalence of opioid dispensings and concurrent gastrointestinal medications in Quebec
    R E Williams
    Worldwide Epidemiology, GlaxoSmithKline, Collegeville, PA 19426 0989, USA
    Pain Res Manag 13:395-400. 2008
  7. ncbi request reprint Epidemiology of opioid pharmacy claims in the United States
    Rachel E Williams
    Worldwide Epidemiology, GlaxoSmithKline, Research Triangle Park, North Carolina, USA
    J Opioid Manag 4:145-52. 2008
  8. doi request reprint Frequency and severity of vasomotor symptoms among peri- and postmenopausal women in the United States
    R E Williams
    Worldwide Epidemiology, GlaxoSmithKline, Research Triangle Park, NC 27709 3398, USA
    Climacteric 11:32-43. 2008
  9. doi request reprint Treatment of symptomatic androgen deficiency: results from the Boston Area Community Health Survey
    Susan A Hall
    New England Research Institutes, Nine Galen Street, Watertown, MA 02474, USA
    Arch Intern Med 168:1070-6. 2008
  10. doi request reprint The natural history of symptomatic androgen deficiency in men: onset, progression, and spontaneous remission
    Thomas G Travison
    New England Research Institutes, Watertown, Massachusetts 02474, USA
    J Am Geriatr Soc 56:831-9. 2008

Detail Information

Publications12

  1. ncbi request reprint Healthcare seeking and treatment for menopausal symptoms in the United States
    Rachel E Williams
    Worldwide Epidemiology, GlaxoSmithKline, PO Box 13398, Mailstop 17 2116, Five Moore Drive, Research Triangle Park, NC 27709 3398, USA
    Maturitas 58:348-58. 2007
    ..A population-based study was used to describe healthcare seeking behavior for menopausal symptoms and treatment among women 40-65 years old in the United States...
  2. pmc Lean mass, muscle strength, and physical function in a diverse population of men: a population-based cross-sectional study
    Andre B Araujo
    New England Research Institutes, Inc, Watertown, MA, USA
    BMC Public Health 10:508. 2010
    ..The objective of this analysis is to examine racial/ethnic differences and racial/ethnic group-specific cross-sectional age differences in measures of muscle mass, muscle strength, and physical function among men...
  3. doi request reprint Menopause-specific questionnaire assessment in US population-based study shows negative impact on health-related quality of life
    Rachel E Williams
    Worldwide Epidemiology, GlaxoSmithKline, PO Box 13398, Mailstop 17 2116, Five Moore Drive, Research Triangle Park, NC 27709 3398, USA
    Maturitas 62:153-9. 2009
    ..To use the Menopause-Specific Quality of Life Questionnaire (MENQOL) to assess the impact of menopausal symptoms on health-related quality of life in a large US population-based study...
  4. ncbi request reprint Stability of irritable bowel syndrome using a Rome II-based classification
    R E Williams
    Worldwide Epidemiology, Glaxo SmithKline, Research Triangle Park, NC 27709, USA
    Aliment Pharmacol Ther 23:197-205. 2006
    ..As there is no biological marker for irritable bowel syndrome, a diagnosis is made using symptom-based criteria...
  5. ncbi request reprint Determinants of healthcare-seeking behaviour among subjects with irritable bowel syndrome
    R E Williams
    Worldwide Epidemiology, GlaxoSmithKline, Research Triangle Park, NC 27709 3395, USA
    Aliment Pharmacol Ther 23:1667-75. 2006
    ..Doctor visits for irritable bowel syndrome are associated with high medical costs. Predictors of medical consultation for irritable bowel syndrome remain poorly understood...
  6. pmc Prevalence of opioid dispensings and concurrent gastrointestinal medications in Quebec
    R E Williams
    Worldwide Epidemiology, GlaxoSmithKline, Collegeville, PA 19426 0989, USA
    Pain Res Manag 13:395-400. 2008
    ..A side effect of opioid usage is the inhibition of gastrointestinal (GI) motility, known as opioid-induced bowel dysfunction (OBD). OBD is typically treated prophylactically with laxatives and/or acid suppressants...
  7. ncbi request reprint Epidemiology of opioid pharmacy claims in the United States
    Rachel E Williams
    Worldwide Epidemiology, GlaxoSmithKline, Research Triangle Park, North Carolina, USA
    J Opioid Manag 4:145-52. 2008
    ..To describe opioid pharmacy claims patterns in the United States among an insured population...
  8. doi request reprint Frequency and severity of vasomotor symptoms among peri- and postmenopausal women in the United States
    R E Williams
    Worldwide Epidemiology, GlaxoSmithKline, Research Triangle Park, NC 27709 3398, USA
    Climacteric 11:32-43. 2008
    ..To describe characteristics of vasomotor symptoms, specifically daily frequency and severity, among women 40-65 years old in the United States (US)...
  9. doi request reprint Treatment of symptomatic androgen deficiency: results from the Boston Area Community Health Survey
    Susan A Hall
    New England Research Institutes, Nine Galen Street, Watertown, MA 02474, USA
    Arch Intern Med 168:1070-6. 2008
    ..We describe patterns and correlates of testosterone treatment in community-dwelling men...
  10. doi request reprint The natural history of symptomatic androgen deficiency in men: onset, progression, and spontaneous remission
    Thomas G Travison
    New England Research Institutes, Watertown, Massachusetts 02474, USA
    J Am Geriatr Soc 56:831-9. 2008
    ..To describe the onset, progression, and remission of symptomatic androgen deficiency (SAD) using longitudinal data from the Massachusetts Male Aging Study (MMAS)...
  11. ncbi request reprint Recognition and treatment of irritable bowel syndrome among women with chronic pelvic pain
    Rachel E Williams
    Department of Epidemiology, School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    Am J Obstet Gynecol 192:761-7. 2005
    ..We sought to describe irritable bowel syndrome (IBS) treatment among women with chronic pelvic pain...
  12. ncbi request reprint Prevalence and characteristics of irritable bowel syndrome among women with chronic pelvic pain
    Rachel E Williams
    Department of Epidemiology, School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
    Obstet Gynecol 104:452-8. 2004
    ..We sought to evaluate whether there are unique characteristics associated with irritable bowel syndrome (IBS) within a population that has chronic pelvic pain...